Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS
Serum prostate-specific antigen (PSA) is currently the most used biomarker in clinical practice for prostate cancer (PCa) detection. However, this biomarker has several drawbacks. In this work, an untargeted gas chromatography-mass spectrometry (GC-MS)-based metabolomic profiling of PCa cells was pe...
Main Author: | |
---|---|
Other Authors: | , , , , , , |
Format: | article |
Language: | eng |
Published: |
2019
|
Online Access: | http://hdl.handle.net/10284/8081 |
Country: | Portugal |
Oai: | oai:bdigital.ufp.pt:10284/8081 |